Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial

Gotlib, J., Reiter, A., Radia, D. H., Deininger, M. W., George, T. I., Panse, J., Vannucchi, A. M., Platzbecker, U., Alvarez-Twose, I., Mital, A., Hermine, O., Dybedal, I., Hexner, E. O., Hicks, L. K., Span, L., Mesa, R., Bose, P., Pettit, K. M., Heaney, M. L., … DeAngelo, D. J. (2021). Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial. Nature Medicine, 27(12), 2192–2199. https://doi.org/10.1038/s41591-021-01539-8
Authors:
Jason Gotlib
Andreas Reiter
Deepti H Radia
Michael W Deininger
Tracy I George
Jens Panse
Alessandro M Vannucchi
Uwe Platzbecker
Iván Alvarez-Twose
Andrzej Mital
Olivier Hermine
Ingunn Dybedal
Elizabeth O Hexner
Lisa K Hicks
Lambert Span
Ruben Mesa
Prithviraj Bose
Kristen M Pettit
Mark L Heaney
Stephen T Oh
Jayita Sen
Hui-Min Lin
Brenton G Mar
Daniel J DeAngelo
Affiliated Authors:
Mark L Heaney
Publication Type:
Article
Unique ID:
10.1038/s41591-021-01539-8
PMID:
Journal:
Publication Date:
Data Source:
PubMed

Record Created: